Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) [Phase 2, Phase 3]
Clinical trial update for COMPANION-002 evaluating CTX-009 in combination with Paclitaxel in adults with unresectable or metastatic biliary …
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel
This clinical trial update describes the use of the EyeMAX 11Fr digital single-operator cholangioscope with a wide working channel in evalua…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 study evaluating the safety of TRK-950 in patients with advanced solid tumors. The study inc…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma [Phase 2, Phase 3]
Phase 2/3 trial evaluating whether [18F] F-FAPI PET-CT changes management in proximal cholangiocarcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
This clinical trial update describes the collection of blood and tissue samples from patients with primary liver cancer to support research.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
This completed clinical trial investigated the relationship between anomalous pancreaticobiliary ductal junction and malignant tumors of the…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer [Phase 3]
Phase 3 trial evaluating adjuvant chemotherapy with gemcitabine and cisplatin versus standard of care after curative resection of biliary tr…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant regimen of tislelizumab, gemcitabine, cisplatin, and S-1 for resectable high-risk…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy [Phase 4]
Phase 4 clinical trial evaluating radiofrequency ablation or photodynamic therapy for non-resectable hilar cholangiocarcinoma; currently rec…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer [Phase 1]
Phase 1 study to determine a safe and potentially effective dose of BI-905711 in patients with advanced gastrointestinal cancers, including …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors [Phase 2]
A phase 2 study evaluating tislelizumab in combination with radiotherapy as a second-line treatment for advanced biliary malignant tumors (c…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal
A completed clinical trial update from Kathmandu University School of Medical Sciences profiling patients with pancreaticobiliary malignanci…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
Clinical trial update examining clinicopathologic characteristics, disease progression, and prognosis in intraductal papillary neoplasm of t…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]
PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
Expanded Access for ABC294640 (Yeliva) in advanced cholangiocarcinoma has been closed and is no longer available.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
Clinical trial update investigating CD24 expression as a potential 'do-not-eat-me' signal in cholangiocarcinoma.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer [Phase 2]
Phase 2 clinical trial evaluating Taxol (paclitaxel) given intravenously and intraperitoneally with Tasigna (nilotinib) taken orally for per…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
This clinical trial update discusses a noninvasive breath test being studied to detect liver cancer and monitor liver conditions, with recru…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study evaluating preoperative Cisplatin, Gemcitabine, and Nab-paclitaxel (GAP) versus immediate resect…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy [NA]
This update describes an ongoing clinical trial evaluating a geriatric intervention for frail patients with gastric, biliary tract (cholangi…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial at Siriraj Hospital is evaluating modified autologous cytokine-induced killer (CIK) cell immunothe…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma [Phase 3]
A Phase 3 clinical trial is evaluating a quadruple therapy regimen with lenvatinib, tislelizumab, gemcitabine, and cisplatin (GPLET) for adv…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
This clinical trial update notes that an early-stage detection study for liver cancer, biliary tract cancer, and pancreatic cancer is curren…
-
CLINICAL_TRIALS other · 2025-02-10Clinical Trial Update: Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of lenvatinib, tislelizumab, gemcitabine, and cisplatin (GPLET) for advanced cholangioca…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements [Phase 3]
Phase 3 trial comparing futibatinib to gemcitabine-cisplatin as first-line treatment for advanced cholangiocarcinoma with FGFR2 gene rearran…